Method and devices for performing cardiac waveform appraisal

• US 7,996,082 B2
• Filed: 07/23/2007
• Issued: 08/09/2011
• Est. Priority Date: 06/02/2003
• Status: Active Grant

• Current Assignee: Cameron Incorporated (Schlumberger NV)
• Original Assignee: Cameron Incorporated (Schlumberger NV)
• Inventors: Phillips, James W., Warren, Jay A., Palreddy, Surekha
• Primary Examiner(s): Manuel; George
• Assistant Examiner(s): Wieland; Robert N
• Application Number:
  US11/781,687
• Publication Number:
  US 20080015647A1
• Time in Patent Office: 1,478 Days
• Field of Search: 600/323, 600/518, 600/513, 607/28, 607/5, 604/66
• US Class Current: 607/5
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/287 Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
• CPC Class Codes: A61B 5/35 by template matching
• CPC Class Codes: A61B 5/7207 of noise induced by motion artifacts
• CPC Class Codes: A61B 5/7239 using differentiation including higher order derivatives
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence

Abstract

Implementations of various technologies described herein are directed toward a sensing architecture for use in cardiac rhythm management devices. The sensing architecture may provide a method and means for certifying detected events by the cardiac rhythm management device. Moreover, by exploiting the enhanced capability to accurately identifying only those sensed events that are desirable, and preventing the use of events marked as suspect, the sensing architecture can better discriminate between rhythms appropriate for device therapy and those that are not.

Claims

1. A method of monitoring cardiac function in an implantable cardiac rhythm device (ICRD), the ICRD comprising a plurality of electrodes adapted for implantation in a patient and operational circuitry electrically coupled to the electrodes and configured to perform analysis of cardiac signals, the method comprising:

monitoring a signal produced between the electrodes;

observing an event in the monitored signal;

gathering a signal corresponding to and including the event in an analysis window;

observing characteristic features of the slope of the signal in the analysis window;

counting the characteristic features to determine the quantity of characteristic features that occur during the analysis window;

comparing the quantity of characteristic features that occur in the signal during the analysis window to a threshold to;

certify the event for use in characterizing a cardiac complex;

or

determine the event is unsuitable for use in characterizing a cardiac complex; and

if the event is certified, using the event to determine whether a malignant cardiac arrhythmia is likely occurring;

or

if the event is not certified, excluding the event from analysis of whether a malignant cardiac arrhythmia is likely occurring.

2. The method of claim 1 wherein:

the step of counting the characteristic features includes identifying an integer value equal to how many characteristic features there are in the signal; and

the step of comparing the quantity of characteristic features to a threshold includes comparing the integer value to the threshold.

3. The method of claim 2 wherein the step of comparing the quantity of characteristic features to the threshold is performed as a single comparison of an integer value to the threshold for each observed event.

4. The method of claim 1, wherein the step of observing characteristic features includes identifying a number of points in the signal where the signal slope reaches a local maximum magnitude, representing zero crossings of the second derivative of the signal.

5. The method of claim 4, wherein the step of observing characteristic features includes:

selecting a first zero crossing of the second derivative as a significant maximum slope point; and

characterizing subsequent zero crossings of the second derivative as either significant maximum slope points or not significant maximum slope points;

wherein the significant maximum slope points are observed to be the characteristic features.

6. The method of claim 4, wherein comparing the quantity of characteristic features that occur during the analysis window to a threshold is performed by:

certifying the event for use in characterizing a cardiac complex if the quantity is less than the threshold; and

determining the event is unsuitable for use in characterizing a cardiac complex is the quantity is greater than the threshold.

7. The method of claim 5, wherein the step of characterizing subsequent zero crossings of the second derivative includes determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds a path length threshold, and:

if so, finding the zero crossing of the second derivative under consideration to be a significant maximum slope point;

if not, ignoring the zero crossing of the second derivative under consideration.

8. The method of claim 7, wherein the path length threshold is related to a selected percentage of the maximum signal amplitude for a chosen cardiac complex.

9. The method of claim 5, wherein the step of characterizing subsequent zero crossings of the second derivative includes application of a rule related to the signal shape between two points in the signal.

10. The method of claim 9, wherein the rule calls for determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds the magnitude of the difference in amplitude between:

the signal at the time of the most recent significant maximum slope point; and

the signal at the time of the zero crossing of the second derivative under consideration.

11. The method of claim 5, wherein the step of characterizing subsequent zero crossings of the second derivative includes analysis using a first rule and a second rule, wherein:

the first rule calls for determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds a path length threshold; and

the second rule calls for determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds the magnitude of the difference in amplitude between;

the signal at the time of the most recent significant maximum slope point; and

the signal at the time of the zero crossing of the second derivative under consideration.

12. The method of claim 1, wherein:

the step of observing characteristic features of the signal includes;

sampling the signal to generate a set samples; and

dividing the sampled signal into divisions each including a plurality of the samples;

the step of counting the characteristics features includes counting how many of the divisions are monotonic to yield a number M; and

the step of comparing the quantity of characteristic features to the threshold includes comparing M to the threshold.

13. A method of cardiac rhythm management using an implantable cardiac rhythm device (ICRD), the ICRD comprising a plurality of electrodes adapted for implantation in a patient and operational circuitry electrically coupled to the electrodes and configured to perform analysis of cardiac signals, the method comprising:

capturing a signal using the electrodes;

analyzing the signal to determine whether the signal is suitable for characterizing a cardiac rhythm;

if the signal is suitable, using the signal to determine whether a malignant cardiac arrhythmia is likely occurring; and

if the signal is not suitable, rejecting the signal;

wherein the step of analyzing the signal to determine whether the signal is suitable for characterizing a cardiac rhythm includes;

sampling the captured signal;

detecting an event in the captured, sampled signal;

selecting a number of samples including the detected event;

dividing the number of samples into a number of divisions each including plurality of samples;

counting how many of the number of divisions are monotonic to yield a number, M; and

comparing M to a threshold;

wherein if M is greater than the threshold, the signal is found to be suitable.

14. An implantable cardioverter/defibrillator (ICD) comprising:

a lead electrode assembly including a number of electrodes; and

a canister housing operational circuitry;

wherein;

the lead electrode assembly is coupled to the canister; and

the operational circuitry is configured to;

monitor a signal produced between the electrodes;

observe an event in the monitored signal;

gather a signal corresponding to and including the event in an analysis window;

observe characteristic features of the shape of the signal in the analysis window;

count the characteristic features to determine the quantity of characteristic features that occur during the analysis window;

compare the quantity of characteristic features that occur in the signal during the analysis window to a threshold to;

certify the event for use in characterizing a cardiac complex;

or

determine the event is unsuitable for use in characterizing a cardiac complex; and

,

if the event is certified, use the event to determine whether a malignant cardiac arrhythmia is likely occurring;

or

if the event is not certified, excluding the event from analysis of whether a malignant cardiac arrhythmia is likely occurring.

15. The ICD of claim 14 wherein the operational circuitry is configured such that:

the step of counting the characteristic features includes identifying an integer value equal to how many characteristic features there are in the signal; and

the step of comparing the quantity of characteristic features to a threshold includes comparing the integer value to the threshold.

16. The method of claim 15 wherein the operational circuitry is configured such that the step of comparing the quantity of characteristic features to the threshold is performed as a single comparison of an integer value to the threshold for each observed event.

17. The ICD of claim 14 wherein the operational circuitry is configured such that the step of observing characteristic features includes identifying a number of points in the signal where the signal slope reaches a local maximum magnitude, representing zero crossings of the second derivative of the signal.

18. The ICD of claim 17 wherein the operational circuitry is configured such that the step of observing characteristic features includes:

selecting a first zero crossing of the second derivative as a significant maximum slope point; and

characterizing subsequent zero crossings of the second derivative as either significant maximum slope points or not significant maximum slope points;

wherein the significant maximum slope points are observed to be the characteristic features.

19. The ICD of claim 17, wherein the operational circuitry is configured such that the step of comparing the quantity of characteristic features that occur during the analysis window to a threshold is performed by:

certifying the event for use in characterizing a cardiac complex if the quantity is less than the threshold; and

determining the event is unsuitable for use in characterizing a cardiac complex is the quantity is greater than the threshold.

20. The ICD of claim 18 wherein the operational circuitry is configured such that the step of characterizing subsequent zero crossings of the second derivative includes analysis using a first rule and a second rule, wherein:

the first rule calls for determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds a path length threshold; and

the second rule calls for determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds the magnitude of the difference in amplitude between;

the signal at the time of the most recent significant maximum slope point; and

the signal at the time of the zero crossing of the second derivative under consideration.

21. The ICD of claim 18 wherein the operational circuitry is configured such that the step of characterizing subsequent zero crossings of the second derivative includes determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds a path length threshold;

and

if so, finding the zero crossing of the second derivative under consideration to be a significant maximum slope point;

if not, ignoring the zero crossing of the second derivative under consideration.

22. The ICD of claim 21 wherein the operational circuitry is configured such that the path length threshold is related to a selected percentage of the maximum signal amplitude for a chosen cardiac complex.

23. The ICD of claim 18 wherein the operational circuitry is configured such that the step of characterizing subsequent zero crossings of the second derivative includes application of a rule related to the signal shape between two points in the signal.

24. The ICD of claim 23 wherein the operational circuitry is configured such that the rule calls for determining whether the path length from a most recent significant maximum slope point to the zero crossing of the second derivative under consideration exceeds the magnitude of the difference in amplitude between:

the signal at the time of the most recent significant maximum slope point; and

the signal at the time of the zero crossing of the second derivative under consideration.

25. The ICD of claim 14 wherein the operational circuitry is configured such that:

the step of observing characteristic features of the signal includes;

sampling the signal to generate a set samples; and

dividing the sampled signal into divisions each including a plurality of the samples;

the step of counting the characteristics features includes counting how many of the divisions are monotonic to yield a number M; and

the step of comparing the quantity of characteristic features to the threshold includes comparing M to the threshold.

26. An implantable cardioverter/defibrillator (ICD) comprising:

a lead electrode assembly including a number of electrodes; and

a canister housing operational circuitry;

wherein;

the lead electrode assembly is coupled to the canister; and

the operational circuitry is configured to;

capture a signal using the electrodes;

analyze the signal to determine whether the signal is suitable for characterizing a cardiac rhythm; and

if the signal is suitable, use the signal to determine whether a malignant cardiac arrhythmia is likely occurring;

if the signal is not suitable, reject the signal;

wherein the operational circuitry is configured such that the step of analyzing the signal to determine whether the signal is suitable for characterizing a cardiac rhythm includes;

dividing the captured signal into a number of samples, and dividing the number of samples into a number of time-contiguous divisions;

counting how many of the number of divisions are monotonic to yield a number, M; and

comparing M to a threshold;

wherein if M is greater than the threshold, the signal is found to be suitable.